{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T02:30:01Z","timestamp":1779935401470,"version":"3.53.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,4,20]],"date-time":"2018-04-20T00:00:00Z","timestamp":1524182400000},"content-version":"am","delay-in-days":354,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Department of Anesthesia, University Hospital Basel, Switzerland"},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["32-118092"],"award-info":[{"award-number":["32-118092"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.nmd.2017.02.008","type":"journal-article","created":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T06:00:22Z","timestamp":1487656822000},"page":"492-499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Resequencing array for gene variant detection in malignant hyperthermia and butyrylcholinestherase deficiency"],"prefix":"10.1016","volume":"27","author":[{"given":"Soledad","family":"Levano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asensio","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Demougin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"R\u00fcffert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Urwyler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2017.02.008_bib0010","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1517\/21678707.2014.880648","article-title":"Malignant hyperthermia: current strategies for effective diagnosis and management","volume":"2","author":"Wappler","year":"2014","journal-title":"Expert Opin Orphan Drugs"},{"key":"10.1016\/j.nmd.2017.02.008_bib0015","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/bja\/aev225","article-title":"European Malignant Hyperthermia Group guidelines for investigation of malignant hyperthermia susceptibility","volume":"115","author":"Hopkins","year":"2015","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.nmd.2017.02.008_bib0020","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13023-015-0310-1","article-title":"Malignant hyperthermia: a review","volume":"10","author":"Rosenberg","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nmd.2017.02.008_bib0025","first-page":"313","article-title":"Pseudocholinesterase deficiency: a comprehensive review of genetic, acquired, and drug influences","volume":"78","author":"Soliday","year":"2010","journal-title":"AANA J"},{"key":"10.1016\/j.nmd.2017.02.008_bib0030","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1213\/01.ane.0000296455.31211.bd","article-title":"Rapid and accurate detection of atypical- and Kalow-variants in the butyrylcholinesterase gene using denaturing high-performance liquid chromatography","volume":"106","author":"Levano","year":"2008","journal-title":"Anesth Analg"},{"key":"10.1016\/j.nmd.2017.02.008_bib0035","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1309\/AJCPPI5KLINEKH7A","article-title":"Concordance of butyrylcholinesterase phenotype with genotype: implications for biochemical reporting","volume":"135","author":"Parnas","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.nmd.2017.02.008_bib0040","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/humu.20356","article-title":"Mutations in RYR1 in malignant hyperthermia and central core disease","volume":"27","author":"Robinson","year":"2006","journal-title":"Hum Mutat"},{"key":"10.1016\/j.nmd.2017.02.008_bib0045","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1471-2350-10-104","article-title":"The role of CACNA1S in predisposition to malignant hyperthermia","volume":"10","author":"Carpenter","year":"2009","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.nmd.2017.02.008_bib0050","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1086\/515454","article-title":"Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle","volume":"60","author":"Monnier","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nmd.2017.02.008_bib0055","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1469-1809.2000.6440307.x","article-title":"Multiple interacting gene products may influence susceptibility to malignant hyperthermia","volume":"64","author":"Robinson","year":"2000","journal-title":"Ann Hum Genet"},{"key":"10.1016\/j.nmd.2017.02.008_bib0060","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/bja\/aep061","article-title":"Mutation screening of the RYR1-cDNA from peripheral B-lymphocytes in 15 Swedish malignant hyperthermia index cases","volume":"102","author":"Broman","year":"2009","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.nmd.2017.02.008_bib0065","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/humu.20878","article-title":"Increasing the number of diagnostic mutations in malignant hyperthermia","volume":"30","author":"Levano","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1016\/j.nmd.2017.02.008_bib0070","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3988\/jcn.2008.4.3.123","article-title":"A double mutation of the ryanodine receptor type 1 gene in a malignant hyperthermia family with multiminicore myopathy","volume":"4","author":"Jeong","year":"2008","journal-title":"J Clin Neurol"},{"key":"10.1016\/j.nmd.2017.02.008_bib0075","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1213\/ANE.0b013e31828a71ff","article-title":"Ryanodine receptor type 1 gene variants in the malignant hyperthermia-susceptible population of the United States","volume":"116","author":"Brandom","year":"2013","journal-title":"Anesth Analg"},{"key":"10.1016\/j.nmd.2017.02.008_bib0080","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s12630-011-9494-6","article-title":"Ryanodine receptor type 1 gene mutations found in the Canadian malignant hyperthermia population","volume":"58","author":"Kraeva","year":"2011","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.nmd.2017.02.008_bib0085","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/humu.9442","article-title":"Frequency and localization of mutations in the 106 exons of the RYR1 gene in 50 individuals with malignant hyperthermia","volume":"27","author":"Galli","year":"2006","journal-title":"Hum Mutat"},{"key":"10.1016\/j.nmd.2017.02.008_bib0090","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/00000542-200606000-00008","article-title":"Malignant hypethermia in Japan \u2013 mutation screening of the entire ryanodine receptor type 1 gene coding region by direct Sequencing","volume":"104","author":"Ibarra","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1016\/j.nmd.2017.02.008_bib0095","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00000542-200503000-00007","article-title":"Screening of the entire ryanodine receptor type 1 coding region for sequence variants associated with malignant hyperthermia susceptibility in the North American population","volume":"102","author":"Sambuughin","year":"2005","journal-title":"Anesthesiology"},{"key":"10.1016\/j.nmd.2017.02.008_bib0100","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1097\/ALN.0000000000000610","article-title":"Next-generation Sequencing of RYR1 and CACNA1S in malignant hyperthermia and exertional heat illness","volume":"122","author":"Fiszer","year":"2015","journal-title":"Anesthesiology"},{"key":"10.1016\/j.nmd.2017.02.008_bib0105","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/bja\/aes341","article-title":"Sequence capture and massively parallel sequencing to detect mutations associated with malignant hyperthermia","volume":"110","author":"Schiemann","year":"2013","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.nmd.2017.02.008_bib0110","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ajmg.a.35243","article-title":"Recessive RYR1 mutations in a patient with severe congenital nemaline myopathy with ophthalomoplegia identified through massively parallel sequencing","volume":"158A","author":"Kondo","year":"2012","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.nmd.2017.02.008_bib0115","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/ALN.0b013e3182a8a998","article-title":"Exome sequencing reveals novel rare variants in the ryanodine receptor and calcium channel genes in malignant hyperthermia families","volume":"119","author":"Kim","year":"2013","journal-title":"Anesthesiology"},{"key":"10.1016\/j.nmd.2017.02.008_bib0120","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/ALN.0b013e3182a8a8e7","article-title":"Using exome data to identify malignant hyperthermia susceptibility mutations","volume":"119","author":"Gonsalves","year":"2013","journal-title":"Anesthesiology"},{"key":"10.1016\/j.nmd.2017.02.008_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2016.00001","article-title":"Cross-comparison of exome analysis, next-generation sequencing of amplicons, and the iPLEX((R)) ADME PGx panel for pharmacogenomic profiling","volume":"7","author":"Chua","year":"2016","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.nmd.2017.02.008_bib0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143199","article-title":"Reliably detecting clinically important variants requires both combined variant calls and optimized filtering strategies","volume":"10","author":"Field","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nmd.2017.02.008_bib0135","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1101\/gr.168393.113","article-title":"Estimating genotype error rates from high-coverage next-generation sequence data","volume":"24","author":"Wall","year":"2014","journal-title":"Genome Res"},{"key":"10.1016\/j.nmd.2017.02.008_bib0140","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/nar\/gku392","article-title":"Performance comparison of SNP detection tools with illumina exome sequencing data-an assessment using both family pedigree information and sample-matched SNP array data","volume":"42","author":"Yi","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.nmd.2017.02.008_bib0145","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1186\/gb-2013-14-5-r51","article-title":"Characterizing and measuring bias in sequence data","volume":"14","author":"Ross","year":"2013","journal-title":"Genome Biol"},{"key":"10.1016\/j.nmd.2017.02.008_bib0150","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13073-016-0269-0","article-title":"Medical implications of technical accuracy in genome sequencing","volume":"8","author":"Goldfeder","year":"2016","journal-title":"Genome Med"},{"key":"10.1016\/j.nmd.2017.02.008_bib0155","article-title":"Development of a high-throughput resequencing array for the detection of pathogenic mutations in osteogenesis imperfecta","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nmd.2017.02.008_bib0160","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/jmg.2010.083345","article-title":"Rapid detection of genetic variants in hypertrophic cardiomyopathy by custom DNA resequencing array in clinical practice","volume":"48","author":"Fokstuen","year":"2011","journal-title":"J Med Genet"},{"key":"10.1016\/j.nmd.2017.02.008_bib0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000918","article-title":"High throughput genetic analysis of congenital myasthenic syndromes using resequencing microarrays","volume":"2","author":"Denning","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nmd.2017.02.008_bib0170","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev-pharmtox-010814-124835","article-title":"Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers","volume":"55","author":"Dunnenberger","year":"2015","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.nmd.2017.02.008_bib0175","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.nmd.2011.03.006","article-title":"King-Denborough syndrome with and without mutations in the skeletal muscle ryanodine receptor (RYR1) gene","volume":"21","author":"Dowling","year":"2011","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2017.02.008_bib0180","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.nmd.2009.12.005","article-title":"Multi-minicore disease and atypical periodic paralysis associated with novel mutations in the skeletal muscle ryanodine receptor (RYR1) gene","volume":"20","author":"Zhou","year":"2010","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2017.02.008_bib0185","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1212\/01.wnl.0000342387.65477.46","article-title":"Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis","volume":"72","author":"Matthews","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2017.02.008_bib0190","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1093\/brain\/awl077","article-title":"Central core disease is due to RYR1 mutations in more than 90% of patients","volume":"129","author":"Wu","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2017.02.008_bib0195","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00401-012-1072-7","article-title":"Impacts of massively parallel sequencing for genetic diagnosis of neuromuscular disorders","volume":"125","author":"Vasli","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.nmd.2017.02.008_bib0200","article-title":"Integrative data mining highlights candidate genes for monogenic myopathies","volume":"9","author":"Abath Neto","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nmd.2017.02.008_bib0205","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1750-1172-8-117","article-title":"Genotype-phenotype correlations in recessive RYR1-related myopathies","volume":"8","author":"Amburgey","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nmd.2017.02.008_bib0210","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/humu.22056","article-title":"Clinical and genetic findings in a large cohort of patients with ryanodine receptor 1 gene-associated myopathies","volume":"33","author":"Klein","year":"2012","journal-title":"Hum Mutat"},{"key":"10.1016\/j.nmd.2017.02.008_bib0215","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/ana.22119","article-title":"RYR1 mutations are a common cause of congenital myopathies with central nuclei","volume":"68","author":"Wilmshurst","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2017.02.008_bib0220","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jmoldx.2015.03.004","article-title":"Confirming variants in next-generation sequencing panel testing by Sanger sequencing","volume":"17","author":"Baudhuin","year":"2015","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.nmd.2017.02.008_bib0225","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jmoldx.2015.04.004","article-title":"Risk of misdiagnosis due to allele dropout and false-positive pcr artifacts in molecular diagnostics analysis of 30,769 genotypes","volume":"17","author":"Blais","year":"2015","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.nmd.2017.02.008_bib0230","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1093\/nar\/gkm348","article-title":"Explaining differences in saturation levels for Affymetrix GeneChip arrays","volume":"35","author":"Skvortsov","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.nmd.2017.02.008_bib0235","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ajhg.2016.06.002","article-title":"Clinical sequencing exploratory research consortium: accelerating evidence-based practice of genomic medicine","volume":"99","author":"Green","year":"2016","journal-title":"Am J Hum Genet"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896616309063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896616309063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:05:54Z","timestamp":1760774754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896616309063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0960896616309063"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2017.02.008","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resequencing array for gene variant detection in malignant hyperthermia and butyrylcholinestherase deficiency","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2017.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}